Physician profile
David F Williams
NPI 1710022017
$15,174.36
in general payments reported to CMS, 2019-2025
46 companies · $2,996 in 2025
The $2,996 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $102 · 2021: $1,510 · 2022: $3,394 · 2023: $3,214 · 2024: $2,975 · 2025: $2,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,910 · Education: $165 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,909.88 |
| Education | $165.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $110.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,488.64 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,900.51 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| W. L. Gore & Associates, INC. | $950.44 | 2019 | |
| Lilly USA, LLC | $877.32 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $769.68 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Amgen INC. | $675.48 | 2022-2025 | Repatha, Otezla, Krystexxa |
| Abbott Laboratories | $611.69 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $570.65 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $548.63 | 2021-2025 | Austedo, Uzedy, Ajovy |
| Regeneron Healthcare Solutions, INC. | $535.65 | 2024-2025 | Dupixent |
| Abbvie INC. | $497.84 | 2021-2025 | |
| Dexcom, INC. | $451.24 | 2021-2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $304.38 | 2023-2025 | Gemtesa |
| Gilead Sciences, INC. | $210.13 | 2022-2023 | Descovy |
| Janssen Pharmaceuticals, INC | $197.16 | 2019-2025 | Xarelto, Spravato |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $186.19 | 2021-2022 | |
| Boston Scientific Corporation | $179.62 | 2022 | |
| Inari Medical, INC. | $167.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Braeburn INC. | $159.57 | 2024-2025 | Brixadi |
| Xeris Pharmaceuticals, INC. | $154.96 | 2022-2023 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $154.38 | 2022 | |
| Astellas Pharma US INC | $147.22 | 2022-2025 | Veozah |
| Genzyme Corporation | $142.42 | 2025 | |
| Novartis Pharmaceuticals Corporation | $139.79 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $121.83 | 2022 | |
| Artivion, INC. | $121.13 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Cryovalve Sg Pulmonary Human Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.21 | 2021-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $104.98 | 2025 | Rexulti |
| Exact Sciences Corporation | $93.16 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $83.48 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $73.92 | 2023-2025 | Edarbi, Edarbi |
| Ethicon US, LLC | $69.95 | 2020 | |
| Alkermes, INC. | $57.77 | 2024-2025 | Vivitrol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.75 | 2021 | |
| Sunovion Pharmaceuticals INC. | $34.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.87 | 2023 | Glassia |
| Lundbeck LLC | $32.54 | 2025 | Rexulti |
| Alexion Pharmaceuticals, INC. | $22.52 | 2021 | |
| Ani Pharmaceuticals, INC. | $22.13 | 2024 | Purified Cortrophin Gel |
| Shield Therapeutics INC | $21.78 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $19.08 | 2023 | Inpefa |
| Arbor Pharmaceuticals, INC. | $18.49 | 2021 | |
| Verona Pharma, INC. | $17.68 | 2025 | Ohtuvayre |
| Insmed, INC. | $17.05 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.15 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.24 | 2024 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.